From Yahoo Finance: 2025-05-14 08:18:00

Wall Street had a mixed finish on Tuesday as investors reacted to lower-than-expected inflation figures. The Consumer Price Index for April rose by only 0.2 percent, bringing the annual inflation rate to 2.3 percent, the lowest since February 2021. The S&P 500 and Nasdaq gained, while the Dow Jones was down. Xenon Pharmaceuticals Inc. (NASDAQ:XENE) dropped by 17.43 percent on Tuesday due to delayed Phase 3 epilepsy study results and poor Q1 earnings performance. The study results are now expected in early 2026. In Q1, net loss widened by 35.7 percent to $65 million, with R&D expenses increasing by 38 percent. XENE ranks 3rd on the list of worst performers.



Read more at Yahoo Finance: Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday